/ /

  • linkedin
  • Increase Font
  • Sharebar

    Intraocular medications gaining traction in cataract procedures

    Modalities target intraoperative miosis and postop pain, inflammation, endophthalmitis


    Though cataract surgeons in 2015 had no new choices of medications to use with their patients, there appeared to be growing interest in options for intraocular administration.

    Speaking to Ophthalmology Times, Malik Y. Kahook, MD, Nick Mamalis, MD, and Mark Packer, MD, discussed modalities targeting intraoperative miosis and postoperative pain, inflammation, and endophthalmitis.

    Intracameral administration of antibiotic for endophthalmitis prophylaxis continues to be a hot topic in cataract surgery, said Dr. Mamalis, professor of ophthalmology, John A. Moran Eye Center, and co-director, Intermountain Ocular Research Center, University of Utah, Salt Lake City.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results